Elaboration et validation de l’iBox, le premier outil universel de prédiction du risque de perte de rein greffé basé sur l’intelligence artificielle.

These contents could be interesting :

Resistance mutations to nirsevimab are rare in respiratory syncytial virus (RSV)

Nirsevimab is an antibody targeting the respiratory syncytial virus (RSV). Available in France since September 2023, it is indicated in neonates and infants for the prevention of bronchiolitis caused....

A promising vaccine against Nipah virus infection

The WHO recently classified the Nipah virus (NiV) as one of the eight main emerging pathogens likely to cause major epidemics in the future. In a context where no....

Medias

Press Contact

Service de presse de l’AP-HP : Eléonore Duveau & Marine Leroy 01 40 27 37 22 freivpr.cerffr@ncuc.seImagine: Béatrice Parrinello-Froment orngevprcneevaryyb@ocspbafrvy.pbz 06 63 72 16 06 Justine Germond whfgvar@ocspbafrvy.pbz 06 30 19 79 77 Céline Giustranti pryvar.tvhfgenagv@vafgvghgvzntvar.bet 01 42 75 43 64 Inserm : cerffr@vafrez.se

Sources

Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study BMJ 2019; 366 doi: https://doi.org/10.1136/bmj.l4923 (Published 17 September 2019)Pandi, A. et al. Metabolic Perceptrons for Neural Computing in Biological Systems. Nature Commun in press, (2019).Use of partially hydrolysed formula in infancy and incidence of eczema, respiratory symptoms or food allergies in toddlers from the ELFE cohort.